Gianluca GAIDANO

Professor of Hematology

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gianluca Gaidano is a Professor of Hematology at the Universita' del Piemonte Orientale / University of Eastern Piedmont, Italy. His research focuses on hematology, with particular emphasis on acute myeloid leukemia, chronic lymphocytic leukemia, B cell lymphomas, and the molecular mechanisms underlying these conditions. Recent publications include studies on next-generation sequencing, resistance to targeted therapies, and the integration of liquid biopsy techniques in clinical practice.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (17)

Luca Laurenti

Università Cattolica del Sacro Cuore

ITALY

Gianluca GAIDANO

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Unraveling the Epigenetic Landscape of Mature B Cell Neoplasia: Mechanisms, Biomarkers, and Therapeutic Opportunities

Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside

Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies

Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma

Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia

Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms

High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System

Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies

High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy

Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers

Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy

Richter Syndrome: From Molecular Pathogenesis to Druggable Targets

New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Updated revision of the British Society of Haematology guidelines for chronic lymphocytic leukaemia

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study

Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Collaborators (17)

Luca Laurenti

ANASTASIOS STATHIS

Marta COSCIA

Stefano Molica

PAOLO SPORTOLETTI

Enrico Berrino

Benedetto Bruno

Nawar Maher

Samir Mouhssine

Roberto Marasca

Donato Mannina

GIOVANNI MARTINELLI

Riccardo Moia

Maria Teresa VOSO

Ilaria DEL GIUDICE

Sabina Chiaretti

ANNALISA CHIAPPELLA

Make your next move.